Market Overview:
The global Radicava market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of neurological disorders, increasing awareness about radicava and its benefits, and growing demand for innovative therapies for neurological disorders. The global Radicava market is segmented on the basis of type (20ml, 100ml), application (hospital, pharmacy), and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). The 20 ml type segment is expected to account for the largest share of the global Radicava market in 2018. This can be attributed to its lower price point as compared to 100 ml type and easy availability. The hospital application segment is expected to account for the largest share of the global Radicava market in 2018. This can be attributed to increasing use of radicava in hospitals owing to its benefits such as improved patient outcomes and reduced treatment costs.
Product Definition:
Radicava (edaravone) is a free radical scavenger that was approved in the United States for the treatment of amyotrophic lateral sclerosis (ALS) in May 2017.
20ml:
20ml is a new product in the Radicava market. It's usage and growth factor are same as other Radicava products, which means it helps to cure cancer, remove skin tags & improve blood circulation.
However, 20ml has one more property that most of the Radicava solutions have - it can be used for pain relief during chemotherapy or radiation therapy. Chemotherapy or radiation damage cells very easily and quickly if not treated at the right time.
100ml:
100ml is a metric measure used for capacity. It is the volume of a cylinder with a diameter of 1m. The 100 ml can be divided into 1000 drops, called as one scruple (abbreviation: ?). One scruple contains? Approximately 65 microliters or 0.0165 fluid ounce.
Application Insights:
Based on the application, the global radicava market is segmented into hospital, pharmacy and others. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high usage rate of radicava for various indications such as cancer treatment, heart diseases and respiratory problems. In addition, an increasing number of hospitals focusing on providing better healthcare services is also expected to drive demand over the forecast period.
The growing prevalence of chronic diseases such as cancer and cardiovascular diseases coupled with rising geriatric population across countries such as China India & Brazil are expected to drive demand for radicava over the forecast period thereby supporting growth in near future.
Regional Analysis:
In 2017, Asia Pacific accounted for the largest share of about 54.0% in terms of revenue and is anticipated to witness significant growth over the forecast period. The presence of a large number of manufacturers coupled with high demand from countries such as India, China and Japan is expected to drive regional market growth during the forecast period. In addition, increasing healthcare expenditure by governments along with rising awareness regarding cancer treatment are some factors that are projected to fuel market development in this region over the coming years.
The product launch by key players including Cipla Inc., Sun Pharmaceutical Industries Ltd., Dr Reddy's Laboratories Ltd., Aurobindo Pharma Pvt Ltd.; GlaxoSmithKline plc; Pfizer Inc.; Novartis AG; Sanofi SA; Merck & Co Inc.; Unilever NV; Abbott Laboratories LLC is also expected to contribute towards regional product penetration during the same period.
Growth Factors:
- Increasing awareness about the benefits of Radicava among physicians and patients
- Growing demand for innovative therapies for ALS
- Launch of new clinical studies to assess the efficacy of Radicava in other neurological conditions
- Expansion of distribution channels for Radicava in key markets
- Increased investment in marketing and sales initiatives to promote awareness about Radicava
Scope Of The Report
Report Attributes
Report Details
Report Title
Radicava Market Research Report
By Type
20ml, 100ml
By Application
Hospital, Pharmacy
By Companies
Mitsubishi Tanabe Pharma, Mitsubishi Tanabe Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
198
Number of Tables & Figures
139
Customization Available
Yes, the report can be customized as per your need.
Global Radicava Market Report Segments:
The global Radicava market is segmented on the basis of:
Types
20ml, 100ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mitsubishi Tanabe Pharma
- Mitsubishi Tanabe Pharma
Highlights of The Radicava Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20ml
- 100ml
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radicava Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radicava is a plant-based supplement that is claimed to help improve the body's ability to fight off infection. It is made from extracts of black walnut, cranberry, and blueberry.
Some of the major players in the radicava market are Mitsubishi Tanabe Pharma, Mitsubishi Tanabe Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radicava Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radicava Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radicava Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radicava Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radicava Market Size & Forecast, 2018-2028
4.5.1 Radicava Market Size and Y-o-Y Growth
4.5.2 Radicava Market Absolute $ Opportunity
Chapter 5 Global Radicava Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Radicava Market Size Forecast by Type
5.2.1 20ml
5.2.2 100ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Radicava Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Radicava Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radicava Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radicava Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Radicava Analysis and Forecast
9.1 Introduction
9.2 North America Radicava Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Radicava Market Size Forecast by Type
9.6.1 20ml
9.6.2 100ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Radicava Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Radicava Analysis and Forecast
10.1 Introduction
10.2 Europe Radicava Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Radicava Market Size Forecast by Type
10.6.1 20ml
10.6.2 100ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Radicava Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Radicava Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Radicava Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Radicava Market Size Forecast by Type
11.6.1 20ml
11.6.2 100ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Radicava Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Radicava Analysis and Forecast
12.1 Introduction
12.2 Latin America Radicava Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Radicava Market Size Forecast by Type
12.6.1 20ml
12.6.2 100ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Radicava Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Radicava Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Radicava Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Radicava Market Size Forecast by Type
13.6.1 20ml
13.6.2 100ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Radicava Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radicava Market: Competitive Dashboard
14.2 Global Radicava Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mitsubishi Tanabe Pharma
14.3.2 Mitsubishi Tanabe Pharma
